Status:
COMPLETED
2NN & CHARM Long-Term Follow-up Study
Lead Sponsor:
International Antiviral Therapy Evaluation Center
Collaborating Sponsors:
Boehringer Ingelheim
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
It is desirable to obtain extended follow up data on subjects who participated in the 2NN study and the CHARM study in order to see if the beneficial effect of using nevirapine continues up to 144 wee...
Detailed Description
The 2NN study has been completed, the first large randomised trial comparing the efficacy and safety of ART containing two nucleoside analogue reverse transcriptase inhibitors (nRTI: d4T+3TC) and eith...
Eligibility Criteria
Inclusion
- Participation in the original 2NN or CHARM study
Exclusion
- None
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
763 Patients enrolled
Trial Details
Trial ID
NCT00127972
Start Date
February 1 2004
End Date
April 1 2007
Last Update
April 30 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Holdsworth House Medical Practice
Darlinghurst, Australia, NSW2010